Welcome back, me! I’ve been vacationing for a week or so, and I’m ready to dive back into the teaser swamps to see what little morsels we might find to discuss. This one was an easy pick for the Thinkolator’s first project of the week: Nick Hodge is pitching one of his newsletters, Wall Street’s […]
Articles
I’ve got a couple things to share with you today — the first is the solution to a teaser from Luke Burgess that’s come out as part of his big “Inflation Nation” promotion that’s more or less in line with all the “dollar doomed” teasers that have dominated the newsletter business in recent months (including […]
I’ve gotten a lot of questions about Luke Burgess’ latest teaser ad for his Underground Profits newsletter, all about what he’s calling “Lake Superior’s $1.9 Trillion Secret” … … and that crafty “Lake Superior secret” phrase might sound familiar — it was used by Greg McCoach’s copywriters a few years ago to pitch some other […]
If there’s one asset class that attracts individual investors like lemmings every time it hits a new high, it’s gold. And if there’s one thing that newsletter publishers know, it’s to sell the people what they want … whether they know they want it or not. So today we’ve got a new high in the […]
Comments
We keep seeing this ad and getting more questions about it -- the ad hasn't changed in any big way that I've noticed, th...
I've often wondered how companies that develop something that eliminates disease, such as this, will make money. The OUT...
$12 trillion? That's over half of the US economy. Even over 10 years, it's never going to happen. I guess for $79/yea...
Well I just hope this is a boomer like the "God Key" stocks (EDIT, CRSP) which are about 50% lower from their peaks in 2...
Although the last three months is a short time period, it's the only one I could research easily. Over that period, the...
I think its cell data. https://www.investors.com/news/technology/crispr-gene-editing-biotech-companies/ https://mo...
There've been a lot of uncertainties around the CRISPR companies, but I think right now the elephant in the room is the ...
Found the article I remember that talks about the patent license. https://www.forbes.com/sites/matthewherper/2015/08/10/...
Amazing how they can predict uranium demand (prices) over the next 15 years or more. After you've spent about $75,000-$...
Thanks for putting everything into perspective. I read about "exciting new developments" every day, and it is impossibl...
I bought CRSP and I am up over 60%. Might think about the other two as well. This technology will take some time to deve...
I gave up on EDIT, NTLA, and CRSP and went with Illumina, Inc. (ILMN) which is similar but much less volatile. And ILMN ...
If you read all the way down to the end of Altucher's epic screed you see that he says you should buy all three: EDIT, N...
I have a really hard time with R&D companies or very early-stage clinical biotechs -- partly because it's an end market ...